Last reviewed · How we verify
NCT06237894
Multisensory Stimulation on Postoperative Pain, Physiological Parameters and Fear in Children
NA trial testing Multisensory Stimulation in Multisensory Stimulation in 80 participants. Status unknown.
15 January 2025
Quick facts
| Lead sponsor | Bilecik Seyh Edebali Universitesi |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 80 |
| Start date | 15 June 2024 |
| Primary completion | 15 January 2025 |
| Estimated completion | 15 June 2025 |
Drugs / interventions tested
- Multisensory Stimulation
Conditions studied
- Multisensory Stimulation — all drugs for Multisensory Stimulation →
- Child, Only — all drugs for Child, Only →
- Postoperative Pain — all drugs for Postoperative Pain →
- Fear — all drugs for Fear →
Sponsor
Bilecik Seyh Edebali Universitesi
Who can join
Adults 5 to 10, any sex, with Multisensory Stimulation or Child, Only. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is known that non-pharmacological methods are effective in reducing pain in children and that they increase the effectiveness of drugs when used together with analgesics. Non-pharmacological methods are preferred because they are easy to apply and cheap, and they reduce the need for drug administration and thus the risk of side effects. Knowing the impact of pain and associated fear on children, developing appropriate pain control strategies is both a medical and ethical responsibility. Reviewing the literature, there is little scientific evidence that multisensory stimulation is an effective intervention in reducing pain and fear after surgery in children. When the studies on the effect of multisensory stimulation on pain and fear in childhood are examined, it is seen that the studies mostly aim to reduce pain and fear in the neonatal period or before surgery. It is thought that it is an important limitation that multisensory stimulation, which is an effective method for reducing pain and fear in childhood, does not examine its direct effects on postoperative pain, physiological parameters and fear after surgical procedures in children. In this context, the aim of the study is to examine the effect of multisensory stimulation on postoperative pain, physiological parameters and fear in children after the surgical procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06237894
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Multisensory Stimulation
Trials testing the same drug.
- NCT07116941 — Multisensory and Cognitive Interventions in the ICU: Effects on Health and Recovery · NA · recruiting
- NCT02589223 — A Trial to Determine the Feasibility and Effectiveness of Early Multisensory Stimulation Intervention in Patients in the · NA · terminated
Other Bilecik Seyh Edebali Universitesi trials
Trials by the same sponsor.
- NCT07461974 — Evaluation of the Effects of Traditional and E-Learning Methods in Cancer Pain Care Education on Learning Outcomes and I · NA · not yet recruiting
- NCT07517341 — Vacuum-Assisted Clipper in Preoperative Hair Removal: Effects on Contamination and Skin Integrity · NA · not yet recruiting
- NCT07329985 — FEAR of HYPOGLYCEMIA in PATIENTS WITH DIABETES · not yet recruiting
- NCT07326163 — The Effect of Peppermint Oil Aromatherapy on Pain, Functional Capacity and Cost in Fibromyalgia Patients · NA · enrolling by invitation
- NCT07316699 — Evaluation of the Psychometric Properties of the Turkish Version of the Hypoglycaemia Self-Care Behaviour Scale · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06237894 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bilecik Seyh Edebali Universitesi
- Last refreshed: 2 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06237894.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing